Table 1. Baseline characteristics of subjects of CAD and control groups.
Variables | CAD | Control | P value | P value * |
---|---|---|---|---|
Mean age (years) | 64.59 ± 9.99 | 63.59 ± 12.41 | 0.145 | 0.174 |
Male/famale | 541/252 | 302/159 | 0.324 | 0.324 |
BMI | 23.13 ± 2.38 | 22.74 ± 2.76 | 0.011 | 0.0165 |
Smokers, n (%) | 249 (31.3) | 54 (11.7) | <0.001 | <0.001 |
Hypertension, n (%) | 323 (40.7) | 78 (16.9) | <0.001 | <0.001 |
Diadetes, n (%) | 234 (29.5) | 41 (8.9) | <0.001 | <0.001 |
Hyperlipidemia | 363 (45.8) | 114 (24.7) | <0.001 | <0.001 |
hs-TnI (μg/L) | 1.91 ± 0.58 | 0.012 ± 0.0022 | <0.001 | <0.001 |
MYO (μg/L) | 140.2 ± 40.46 | 25.69 ± 1.43 | <0.001 | <0.001 |
CK (μg/L) | 207.5 ± 91.53 | 64.13 ± 3.39 | <0.001 | <0.001 |
CK-MB (μg/L) | 43.76 ± 4.028 | 17.37 ± 1.17 | <0.001 | <0.001 |
Glu (mmol/L) | 6.50 ± 6.45 | 5.84 ± 1.97 | 0.008 | 0.0137 |
CHOL (mg/Dl) | 4.92 ± 1.29 | 4.81 ± 1.22 | 0.158 | 0.172 |
TG (mmol/L) | 1.65 ± 1.07 | 1.49 ± 1.10 | 0.017 | 0.0227 |
HDL (mmol/L) | 1.28 ± 0.38 | 1.35 ± 0.41 | 0.006 | 0.012 |
LDL (mmol/L) | 2.89 ± 1.12 | 2.60 ± 1.13 | <0.001 | <0.001 |
Abbreviations: CAD, coronary arterial disease; BMI, body mass index; Glu, blood sugar; CHOL, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; hs-TnI, high-sensitive troponin I; MYO, myoglobin; CK, creatine kinase; CK-MB, creatine kinase-isoenzyme. Continuous data are expressed as the mean ± SEM. Adjusted for age, sex, smoking, hypertension, diadetes and hyperlipidemia.
*False discovery rate-adjusted P value for multiple hypotheses test using BH method.